Want to join the conversation?
$REGN's average headcount in 3Q15 rose to 3,966 from 2,714 in the previous year quarter. Total operating expenses grew to $745MM from $537.3MM, due to higher non-cash compensation expense related to employee stock option and restricted stock awards. Research and development expenses increased to $425.9MM from $337.7MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.